Cordlife Group Limited (SGX:P8A)

Market Cap	38.19M +9.6%
Revenue (ttm)	37.73M +14.2%
Net Income	-12.05M
EPS	-0.05
Shares Out	256.31M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	13,400
Average Volume	31,585
Open	0.1490
Previous Close	0.1490
Day's Range	0.1490 - 0.1490
52-Week Range	0.1210 - 0.3300
Beta	0.70
RSI	50.73
Earnings Date	Feb 26, 2026

About Cordlife Group

Cordlife Group Limited, an investment holding company, provides cord blood banking services in Singapore, Hong Kong, India, Malaysia, the Philippines, and internationally. It operates in two segments, Banking and Diagnostics. The Banking segment collects, processes, banks, and tests biological materials, such as cord blood, lining, and tissue samples. The Diagnostics segment offers diagnostic testing services, such as newborn genetic and metabolic screenings; pediatric vision and ear screenings; pediatric allergen test; and genetic talent test ...

• Industry: Medical - Diagnostics & Research
• Sector: Healthcare
• Founded: 2001
• Employees: 538
• Stock Exchange: Singapore Exchange
• Ticker Symbol: P8A